139 related articles for article (PubMed ID: 2785400)
1. Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue.
Thyss A; Milano G; Etienne MC; Paquis P; Roche JL; Grelier P; Schneider M
Br J Cancer; 1989 Apr; 59(4):627-30. PubMed ID: 2785400
[TBL] [Abstract][Full Text] [Related]
2. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
4. l-folinic acid versus d,l-folinic acid in rescue of high-dose methotrexate therapy in children.
Etienne MC; Thyss A; Bertrand Y; Touraine R; Rubie H; Robert A; Milano G
J Natl Cancer Inst; 1992 Aug; 84(15):1190-5. PubMed ID: 1635087
[TBL] [Abstract][Full Text] [Related]
5. The inability of oral leucovorin to elevate CSF 5-methyl-tetrahydrofolate following high dose intravenous methotrexate therapy.
Allen J; Rosen G; Juergens H; Mehta B
J Neurooncol; 1983; 1(1):39-44. PubMed ID: 6611387
[TBL] [Abstract][Full Text] [Related]
6. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
Mehta BM; Glass JP; Shapiro WR
Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
[TBL] [Abstract][Full Text] [Related]
7. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution.
Ramaekers VT; Häusler M; Opladen T; Heimann G; Blau N
Neuropediatrics; 2002 Dec; 33(6):301-8. PubMed ID: 12571785
[TBL] [Abstract][Full Text] [Related]
8. Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue.
Kamen BA; Vietti T
Br J Cancer; 1989 Nov; 60(5):799. PubMed ID: 2803957
[No Abstract] [Full Text] [Related]
9. High-performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid.
Belz S; Frickel C; Wolfrom C; Nau H; Henze G
J Chromatogr B Biomed Appl; 1994 Nov; 661(1):109-18. PubMed ID: 7866539
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.
Sterba J; Dusek L; Demlova R; Valik D
Clin Chem; 2006 Apr; 52(4):692-700. PubMed ID: 16455868
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment.
Tubiana-Mathieu N; Monjanel-Mouterde S; Lejeune C; Payet B; Catalin J; Carcassonne Y; Cano J
Eur J Cancer; 1994; 30A(9):1281-4. PubMed ID: 7999413
[TBL] [Abstract][Full Text] [Related]
12. CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism.
Shoffner J; Trommer B; Thurm A; Farmer C; Langley WA; Soskey L; Rodriguez AN; D'Souza P; Spence SJ; Hyland K; Swedo SE
Neurology; 2016 Jun; 86(24):2258-63. PubMed ID: 27178705
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.
Mader RM; Steger GG; Rizovski B; Sieder AE; Locker G; Gnant MF; Jakesz R; Rainer H
Br J Clin Pharmacol; 1994 Mar; 37(3):243-8. PubMed ID: 8198932
[TBL] [Abstract][Full Text] [Related]
14. Reduced dose folinic acid rescue after rapid high-dose methotrexate clearance is not associated with increased toxicity in a pediatric cohort.
Niinimäki R; Aarnivala H; Banerjee J; Pokka T; Vepsäläinen K; Harila-Saari A
Support Care Cancer; 2022 Jan; 30(1):127-133. PubMed ID: 34235555
[TBL] [Abstract][Full Text] [Related]
15. Levels of 5-methyltetrahydrofolate and ascorbic acid in cerebrospinal fluid are correlated: implications for the accelerated degradation of folate by reactive oxygen species.
Aylett SB; Neergheen V; Hargreaves IP; Eaton S; Land JM; Rahman S; Heales SJ
Neurochem Int; 2013 Dec; 63(8):750-5. PubMed ID: 24140430
[TBL] [Abstract][Full Text] [Related]
16. Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations.
Verbeek MM; Blom AM; Wevers RA; Lagerwerf AJ; van de Geer J; Willemsen MA
Mol Genet Metab; 2008 Nov; 95(3):127-32. PubMed ID: 18722797
[TBL] [Abstract][Full Text] [Related]
17. [Meningeal passage of folinic acid in treatment protocols using LAL with methotrexate in children].
Etienne MC; Milano G; Thyss A; Deville A; Manassero J
Bull Cancer; 1989; 76(8):867-70. PubMed ID: 2620113
[No Abstract] [Full Text] [Related]
18. Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system.
Cohen IJ
J Pediatr Hematol Oncol; 2004 Mar; 26(3):156-63. PubMed ID: 15125607
[TBL] [Abstract][Full Text] [Related]
19. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.
Surtees R; Clelland J; Hann I
J Clin Oncol; 1998 Apr; 16(4):1505-11. PubMed ID: 9552059
[TBL] [Abstract][Full Text] [Related]
20. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study.
Hagebeuk EE; Duran M; Koelman JH; Abeling NG; Vyth A; Poll-The BT
J Child Neurol; 2012 Mar; 27(3):304-9. PubMed ID: 21868372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
